Australia Markets closed

Nascent Biotech, Inc. (NBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0500-0.0050 (-9.09%)
At close: 03:47PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
372.12
172.186
94.414
1.435
-
Total cash
372.12
172.186
94.414
1.435
-
Net receivables
-
-
0
750
0
Total current assets
552.12
255.002
105.414
751.435
-
Non-current assets
Total non-current assets
0
0
0
0
-
Total assets
552.12
255.002
105.414
751.435
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
122.5
389.591
-
161.736
138.815
Accounts payable
686.294
498.122
776.89
636.831
-
Other current liabilities
-
663.426
-
302.156
603.836
Total current liabilities
808.794
1,551
776.89
1,224
-
Non-current liabilities
Total non-current liabilities
0
0
0
0
-
Total liabilities
808.794
1,551
776.89
1,224
-
Stockholders' equity
Common stock
170.594
131.764
111.313
104.888
-
Retained earnings
-24,260
-21,623
-18,822
-18,351
-
Total stockholders' equity
-256.674
-1,296
-671.476
-472.505
-
Total liabilities and stockholders' equity
552.12
255.002
105.414
751.435
-